Skip to main content
OpenTrials

Clinical trial condition

Relapsed and/or Refractory Multiple Myeloma (RRMM)

Explore clinical trials studying Relapsed and/or Refractory Multiple Myeloma (RRMM). Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Relapsed and/or Refractory Multiple Myeloma (RRMM) trial results

Recruiting

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT07222761

Conditions
Relapsed and/or Refractory Multiple Myeloma (RRMM)
Locations
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • OhioHealth Columbus, Ohio, United States
  • University of Texas Health Science Center, Houston Houston, Texas, United States
View all 20 locations
View Trial Details

Related conditions